Literature DB >> 24047975

Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era.

Paul G Farnham1, David R Holtgrave, Chaitra Gopalappa, Angela B Hutchinson, Stephanie L Sansom.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24047975     DOI： 10.1097/QAI.0b013e3182a5c8d4

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  16 in total

1.  The Cost-Effectiveness of Syphilis Screening Among Men Who Have Sex With Men: An Exploratory Modeling Analysis.

Authors:  Harrell W Chesson; Sarah Kidd; Kyle T Bernstein; Robyn Neblett Fanfair; Thomas L Gift
Journal:  Sex Transm Dis       Date:  2016-07       Impact factor: 2.830

2.  Cost-Utility of Access to Care, a National HIV Linkage, Re-engagement and Retention in Care Program.

Authors:  Catherine Maulsby; Kriti M Jain; Brian W Weir; Blessing Enobun; Melissa Werner; Morey Riordan; David R Holtgrave
Journal:  AIDS Behav       Date:  2018-11

3.  Adherence and Viral Suppression Among Participants of the Patient-centered Human Immunodeficiency Virus (HIV) Care Model Project: A Collaboration Between Community-based Pharmacists and HIV Clinical Providers.

Authors:  Kathy K Byrd; John G Hou; Tim Bush; Ron Hazen; Heather Kirkham; Ambrose Delpino; Paul J Weidle; Michael D Shankle; Nasima M Camp; Sumihiro Suzuki; Patrick G Clay
Journal:  Clin Infect Dis       Date:  2020-02-14       Impact factor: 9.079

4.  The lifetime medical cost savings from preventing HIV in the United States.

Authors:  Bruce R Schackman; John A Fleishman; Amanda E Su; Bethany K Berkowitz; Richard D Moore; Rochelle P Walensky; Jessica E Becker; Cindy Voss; A David Paltiel; Milton C Weinstein; Kenneth A Freedberg; Kelly A Gebo; Elena Losina
Journal:  Med Care       Date:  2015-04       Impact factor: 2.983

5.  "The one who doesn't take ART medication has no wealth at all and no purpose on Earth" - a qualitative assessment of how HIV-positive adults in Uganda understand the health and wealth-related benefits of ART.

Authors:  Uzaib Saya; Sarah MacCarthy; Barbara Mukasa; Peter Wabukala; Lillian Lunkuse; Zachary Wagner; Sebastian Linnemayr
Journal:  BMC Public Health       Date:  2022-05-27       Impact factor: 4.135

6.  The Cost and Cost-utility of Three Public Health HIV Case-finding Strategies: Evidence from Rhode Island, 2012-2014.

Authors:  Xinqi C Li; Lillian Kusi; Theodore Marak; Thomas Bertrand; Philip A Chan; Omar Galárraga
Journal:  AIDS Behav       Date:  2018-11

7.  Methods for Sexually Transmitted Disease Prevention Programs to Estimate the Health and Medical Cost Impact of Changes in Their Budget.

Authors:  Harrell W Chesson; Jennifer A Ludovic; Andrés A Berruti; Thomas L Gift
Journal:  Sex Transm Dis       Date:  2018-01       Impact factor: 2.830

8.  Cost-Effectiveness Analysis Combining Medical and Mental Health Services for Older Adults with HIV in New York City.

Authors:  Juan J DelaCruz; Christos Giannikos; Andreas Kakolyris; Robert C Utzinger; Stephen E Karpiak
Journal:  Atl Econ J       Date:  2021-03-08

9.  Clinical and Economic Effects of a Pharmacist-Administered Antiretroviral Therapy Adherence Clinic for Patients Living with HIV.

Authors:  Thomas J Dilworth; Pamela W Klein; Renée-Claude Mercier; Matthew E Borrego; Bernadette Jakeman; Steven D Pinkerton
Journal:  J Manag Care Spec Pharm       Date:  2018-02

10.  A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis.

Authors:  David W Dowdy; Jason R Andrews; Peter J Dodd; Robert H Gilman
Journal:  Elife       Date:  2014-06-04       Impact factor: 8.140
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.